Drupal.behaviors.print = function(context) {window.print();window.close();}>
Sengenics to Use OGT's Protein Array Platform for Cancer Biomarker Discovery, Clinical Trials Service
March 08, 2013
Sengenics to Use OGT's Protein Array Platform for Cancer Biomarker Discovery, Clinical Trials Service
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
OGT's Protein Array at Heart of Sengenics Deal, Test-Development Programs
March 19, 2013 / BioArray News
OGT to Use Protein, MiRNA Platforms in Biomarker-Discovery Pact with Abcodia
November 8, 2011 / BioArray News
In Bid to Court Cancer Cyto Community, OGT Prepares CCMC-Designed Chip for Launch
February 26, 2013 / BioArray News
OGT CEO Cites 'Exceptional Demand' for Cyto Chips in Decision to Establish US Office
November 27, 2012 / BioArray News
OGT to Debut New Chip for Cancer Cytogenetics; Expand Sequencing Services
June 26, 2012 / BioArray News